Tertiary Prevention of HBV-related HCC in Asia

Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC

“…6 Whilst increasing treatment options were available for HCC over the past decade, 7,8 NA treatment is 1 of the key modalities for secondary and tertiary prevention for HCC. 9 Unfortunately, the uptake rate of antiviral treatment could be as low as 5% even in developed countries. 10 This consequence increases the likelihood of hepatic decompensation and hence limits the HCC treatment options.…”